Location: London (Hybrid)
Please only apply if you can start immediately.
Genomics is a science-led transatlantic TechBio combining large-scale genetic and health data with proprietary analytics to accelerate drug discovery and advance predictive, preventative healthcare. We are united by a single vision to help people live longer, healthier lives, using the power of genomics.
Genomics aims to help people live longer, healthier lives in two ways: super-charging drug discovery and development for novel treatments with our AI-enabled advanced genetic analytics platform, and by helping people understand their personal risk of common chronic diseases through polygenic risk scores - giving doctors and health systems the chance to get the right people into the right prevention, screening and treatment programmes at the right time.
We're building a dedicated delivery team around one of our most important partnerships, and we need an experienced Project Manager to make it work.
This is a client-facing role with the feel of a consulting engagement. You'll set up and embed a multidisciplinary team, then coordinate delivery across our various internal functions
We are committed to providing a transparent, supportive, and rewarding work environment.
If you're ready to step into a high-impact, six-month engagement where you'll build a team and deliver for a major pharma partner, we'd love to hear from you. This role has an immediate start, so apply now!
We are dedicated to creating a diverse environment and are proud to be an equal-opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
Genomics politely requests no contact from recruitment agencies. We do not accept speculative CVs from recruitment agencies nor accept the fees associated with them.

We are a pioneering transatlantic TechBio company that aims to transform health through the power of genomics. The company was formed in 2014 by four world-leading statistical and human geneticists at the University of Oxford, including Professor Sir Peter Donnelly and Professor Gil McVean. We use large-scale genetic information to realise preventative medicine and improve drug discovery.
We're a world-leader in genomic prevention: a paradigm-changing approach to sustainable healthcare which for the first time allows reliable, personalised estimates of risk for all the common diseases and cancers, well ahead of disease manifestation, allowing accurate and early interventions and tailored screening.
Our proprietary algorithms and databases offer something no competitor can: the ability to accurately link minute variation across the entire genome to changes in thousands of biological measurements and disease outcomes, to generate population-level insights for healthcare systems, individual-level insights for clinicians about the risk of common diseases, and new understanding of disease processes.
We work with leading life sciences and biotech companies, including Novo Nordisk and Vertex.
Our team is a multi-disciplinary group of world experts focused on finding powerful and creative solutions for bringing subject-leading science to as wide an audience as possible, and, in doing so, offer the chance of transforming lives around the world.
The workforce is highly qualified and consists of over 150 people, including world-leading genomic scientists, computational biologists, statisticians, software engineers, product developers, data scientists and commercial strategists.
We are headquartered in Oxford, with offices in Cambridge (UK), London (UK), and North Carolina (US), with labs in Framingham (US).